Optimize Health, the Nation’s Leading Remote Care Company for Physicians, Has Been Named to Inc. 5000 Fastest-Growing Companies in the U.S.

Optimize Health, the Nation’s Leading Remote Care Company for Physicians, Has Been Named to Inc. 5000 Fastest-Growing Companies in the U.S.

Inc. revealed today that Optimize Health, one of the nation’s most trusted remote care platforms, has been ranked No. 679 on the annual Inc. 5000 list, the prestigious ranking of the fastest-growing private companies in America. The list represents a unique data-driven look at the economy’s most dynamic segment — its independent, entrepreneurial businesses — and is a key achievement for a growing business. 

“Optimize Health is honored to be recognized by Inc. as one of America’s most successful private companies,” said Todd Haedrich, CEO of Optimize Health. “The past two years have been transformational for Optimize Health, and being named to the Inc. 5000 is a testament to the incredible success of our customers and the industry-leading product our team has built. Now, we’re focused on further accelerating our momentum as the leader in remote care and empowering physicians, their teams and their patients to take control of their chronic conditions. We are just getting started in enabling digital healthcare to provide better outcomes for everyone.” 

Health systems, physician practices, federally qualified health centers (FQHC), accountable care organizations (ACO), and large medical groups have been turning to Optimize Health to transform their care delivery. It is estimated that 6 in 10 Americans have at least one chronic condition and more than $3.7 trillion is spent annually for the management and treatment of these conditions. Optimize Health’s clinician-focused platform built around remote care enables healthcare organizations to easily and effectively deliver remote patient monitoring, enhance the patient-provider relationship, improve practice workflows and help thousands of physicians and over 50,000 patients to gain control of their chronic conditions. Respectively, Inc. ranked Optimized Health No. 58 in Health Services.

The Inc. 5000 class of 2023 represents companies that have driven rapid revenue growth while navigating inflationary pressure, the rising costs of capital, and seemingly intractable hiring challenges. 

“Running a business has only gotten harder since the end of the pandemic,” says Inc. editor-in-chief Scott Omelianuk. “To make the Inc. 5000 — with the fast growth that requires — is truly an accomplishment. Inc. is thrilled to honor the companies that are building our future.”

“Being recognized as one of the fastest-growing companies in the U.S., in light of recent economic headwinds, shows the potential of remote care, remote patient monitoring and chronic care management. Here at Optimize, our world-class team is committed to continue delivering high-quality products and services to help physicians. We thank our physicians, their patients and our partners for putting trust in us,” says Haedrich. 

For complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, location, and other criteria, go to www.inc.com/inc5000.

About Optimize Health 

Optimize Health is revolutionizing the healthcare industry through its innovative technology and patient + care team-centric approach. The company leverages cutting-edge Remote Patient Monitoring technology and easy-to-use devices to improve patient outcomes, enhance clinical decision-making, and optimize operational efficiency for healthcare providers. We’re on a mission to transform how medical groups use technology and real-time data to treat patients outside the practice walls. As the leader in remote care solutions, we help physicians deliver proactive care that re-centers the patient and provider relationship and improves patient outcomes and their quality of life. For more information, visit optimize.health.

Contact Information:

Todd Haedrich

CEO

[email protected]

Original Source:

Optimize Health, the Nation’s Leading Remote Care Company for Physicians, Has Been Named to Inc. 5000 Fastest-Growing Companies in the U.S.

The post Optimize Health, the Nation’s Leading Remote Care Company for Physicians, Has Been Named to Inc. 5000 Fastest-Growing Companies in the U.S. first appeared on Enrose Magazine.

Continue Reading

Radical Imaging and Medicai Partner Together to Integrate FlexView in Medicai’s Platform

Radical Imaging and Medicai Partner Together to Integrate FlexView in Medicai’s Platform

Radical Imaging Partners with Medicai to Provide an All-in-One Medical Imaging Infrastructure, Workflows Management System and Viewer Solution

Radical Imaging and Medicai Partner Together to Integrate FlexView in Medicai’s Platform
FlexView and Medicai

FlexView + Medicai

Radical Imaging LLC, a pioneer in medical imaging informatics, interoperability, and integrations, announced today that it is partnering with Medicai, a provider of decentralized cloud-based infrastructure (PACS, VNA and exchange) that enables healthcare providers to seamlessly and securely manage and exchange imaging data. This partnership will enable Medicai’s customers to easily opt-in to use FlexView as their viewer in Medicai’s platform and FlexView’s customers to have Medicai’s ready-made solution when it is required that they use a central repository for medical images and associated patient data from multiple healthcare systems in conjunction with the viewer. 

FlexView is a professionally supported, SaaS cloud medical imaging viewer created by Radical Imaging that is based on the Open Health Imaging Foundation (OHIF) framework. It is a commercial-grade, production-ready solution that can easily be incorporated into any medical imaging system, seamlessly providing the viewing and analysis capabilities for any type of medical image or workflow. FlexView adds to OHIF’s extensibility model by introducing the ability to deploy plugins at runtime. This is crucial to enable the addition of new features dynamically, such as AI-based tools, without causing disruptions or system downtime. Users will be able to discover, opt into and use these value-added services as they become available in the FlexView Extension Marketplace. FlexView will be available to the general public in September 2023.

Medicai’s cloud-based platform provides physicians with instant access to patient medical images, such as X-rays, CT scans, and MRIs, and other relevant medical files, regardless of location. It enables them to view and analyze medical images, make diagnoses, and collaborate with other medical professionals across different healthcare settings in real-time to make more informed decisions about patient treatment. The platform is designed to be user-friendly and scalable, allowing healthcare providers to easily access and share imaging data across a network of providers.  

Medicai’s interoperable medical imaging architecture enables seamless communication and data exchange between different medical imaging systems and healthcare applications, regardless of the vendor or technology used. The platform is built on industry-standard protocols, including DICOM and HL7, ensuring that it can easily integrate with other healthcare systems, such as Electronic Health Records (EHRs) and Picture Archiving and Communication Systems (PACS). A vendor-neutral archive (VNA) is included, which acts as a central repository for medical images and associated patient data, and supports various DICOM standards and image formats. A set of interfaces and APIs (Application Programming Interfaces) that enable different systems and applications to communicate with each other is also included, promoting interoperability and enabling more efficient workflows. 

“We are excited to have FlexView fully integrated into Medicai’s platform on day one of our launch of FlexView. This integration will benefit both Medicai’s existing customers and FlexView’s future customers by having a best-in-class, all-in-one medical imaging infrastructure and viewer solution at the ready when required,” said Rob Lewis, CEO of Radical Imaging.

About Radical Imaging LLC

Radical Imaging is a software company focused entirely on medical imaging. It offers software system design and planning, contract software development and consulting to help its partners solve their most challenging medical imaging problems using modern cloud and web platforms like Cornerstone.js and OHIF which it co-developed with Massachusetts General Hospital. In 2023, Radical Imaging will be releasing its first commercial product, FlexView, a commercial version of OHIF. For more information, visit RadicalImaging.com.

About Medicai

Medicai is an awarded suite of software systems for organizations working with medical imaging: imaging centers, hospitals, and specialized providers, offering fully secure and compliant imaging data management. Medicai’s software components include: a cloud-native, decentralized medical imaging infrastructure and workflows management system, web and mobile applications for doctors and patients to collaborate on imaging data, and a cost-effective data archiving solution. For more information, please visit medicai.io.

Contact Information:

Radical Imaging

[email protected]

Original Source:

Radical Imaging and Medicai Partner Together to Integrate FlexView in Medicai’s Platform

The post Radical Imaging and Medicai Partner Together to Integrate FlexView in Medicai’s Platform first appeared on Enrose Magazine.

Continue Reading

Washington Plastic Surgeon Javad Sajan, MD, Donates to Homeless Women After Successful Mother’s Day Drive at Allure Esthetic

Washington Plastic Surgeon Javad Sajan, MD, Donates to Homeless Women After Successful Mother’s Day Drive at Allure Esthetic

Allure Esthetic’s Mother’s Day Drive in Seattle Donates Diapers, Supplies to Mary’s Place

In the lead-up to Mother’s Day 2023, Seattle plastic surgeon Dr. Javad Sajan’s practice, Allure Esthetic Plastic Surgery, collected donations for mothers experiencing homelessness in the community. This included physical donations in the office and monetary donations directly to the Zera Foundation, the partnering nonprofit organization.

With collection boxes at all three locations, Dr. Sajan offered five free units of Botox to anyone who donated two or more items to the drive. Allure Esthetic frequently works with the 501c3 nonprofit, the Zera Foundation to make a difference in the lives of families in transition and underprivileged populations.

In a video about the fundraiser, Javad Sajan, MD says, “We’re so excited to partner with our community to help people who are going through a difficult transition in life.” Allure Esthetic also hosts other fundraising events throughout the year such as a Thanksgiving Food Drive and School Supplies Drive.

On July 22nd, Dr. Sajan hand-delivered the donations to Mary’s Place, a shelter and organization that supports women and families, in Seattle. The donations consisted of diapers, wipes, and other items necessary for mothers and children of all ages. All donations stay within the community and uplift women and children in need.

About Javad Sajan, MD: Javad Sajan, MD is a plastic surgeon in Seattle, Washington. His practice Allure Esthetic Plastic Surgery provides plastic surgery and life-saving gender affirming surgery to patients from all around the world. Allure Esthetic and Javad Sajan, MD regularly participate in the community through item collection drives and fundraisers that benefit families and children in the Great Seattle area. Find Dr. Sajan, Allure Esthetic, and their community service efforts on Instagram @realdrseattle.

Contact Information:

Allure Esthetic

[email protected]

206-209-0988

Original Source:

Washington Plastic Surgeon Javad Sajan, MD, Donates to Homeless Women After Successful Mother’s Day Drive at Allure Esthetic

Washington Plastic Surgeon Javad Sajan, MD, Donates to Homeless Women After Successful Mother’s Day Drive at Allure Esthetic

The post Washington Plastic Surgeon Javad Sajan, MD, Donates to Homeless Women After Successful Mother’s Day Drive at Allure Esthetic first appeared on Enrose Magazine.

Continue Reading

Apprentice Announces Major Tempo Manufacturing Cloud Release Built to Support Commercial Manufacturing of the Future

Apprentice Announces Major Tempo Manufacturing Cloud Release Built to Support Commercial Manufacturing of the Future

Updates to Tempo’s Manufacturing Execution System and Connected Manufacturing Network Drive Greater Efficiency and Scalability

Apprentice Announces Major Tempo Manufacturing Cloud Release Built to Support Commercial Manufacturing of the Future
Visual Step Builder

Develop complex procedure workflows through a click-and-drag visual flow of steps for easier process design for scientists.

Apprentice, which helps life science manufacturers get treatments to patients faster by providing one platform to turn molecules into medicine, announced today a major release to its Tempo Manufacturing Cloud, focused on extending product capabilities for modern commercial manufacturing.

The 7.0 Release deepens Tempo’s existing features in its Manufacturing Execution System (MES) that support commercial production and adds a new product, the Connected Manufacturing Network (CMN), that creates a connected digital network across internal and external sites. 

Deepening Manufacturing Execution System (MES) Capabilities

“We want to help our customers navigate today’s complex manufacturing environment as drug therapies become more specialized and scalability becomes more important,” said Angelo Stracquatanio, CEO & Co-founder of Apprentice.io. “With the 7.0 release, we’re building the technological innovation that will directly reduce cost, increase speed, and maximize yield of commercial manufacturing so that lifesaving medicines get to patients in need.”

In addition to 30+ new features and enhancements, seven key new capabilities standout:

  • Visual step builder: Develop complex procedure workflows through a click-and-drag visual flow of steps for easier process design for scientists.
  • Kitting: Use and consume predefined resource sets instead of searching for individual components in order to streamline procedures and save valuable time.
  • Automatic step execution: Execute actions within a procedure step, such as calculations or scanning equipment, in addition to creating steps that connect to other equipment or even other systems with in-step integration.
  • Remote Assistance: Adapt to constant change during execution and drive faster reviews with real-time embedded video conferencing from a procedure run.
  • Conditional Step Navigation: Guide an operator to one of several procedure step options using ‘if’, ‘if then’, or ‘else’ statements based on the result of the previous step.
  • New integrations:  Start batch runs directly from an External DCS to support automated batch runs.
  • Web execution: Gain greater operational flexibility with the new ability to execute from your web browser, in addition to Tempo’s iPad and wearable headset.

The Connected Manufacturing Network

The 7.0 release also includes the new CMN product. Tempo’s CMN enables you to drive value at the site-level, the enterprise-level, and across external partners. To achieve this, CMN brings together four powerful capabilities:

  • Product Lifecycle Data: Consolidate data for each stage of a drug’s lifecycle in one place.
  • Enterprise Recipe Management: Optimize enterprise recipe management across environments and sites.
  • External Manufacturing Collaboration: Ditch email and calls for automated communications.
  • Tech Transfer: Quickly and easily move all your master resources and data.

These key tools allow you to coordinate the materials, equipment, recipes, and personnel needed to plan, execute, test, and release a batch from one shared system to accelerate the end-to-end drug production lifecycle.

Launching Tempo with the Team

Apprentice held a virtual launch event on Tuesday with 100+ attendees highlighting the new commercial functionality and the success of its recently released CMN package.

Event sessions covered everything from Apprentice’s more sophisticated commercial manufacturing capabilities to its new quarterly release cadence, additional quality updates, and the formation of its partner program. 

“We have a clear vision for building a product that can support the future of commercial manufacturing and connect enterprise-wide operations across internal and external sites and teams,” said Jean Barmash, CTO at Apprentice. “We will continue to up-level our product capabilities and standardize our approach so that our customers can rely on one system for accelerating critical drug production.”

About Apprentice

Apprentice helps life science manufacturers get therapeutics to patients faster by providing one platform to turn molecules into medicine. Our Tempo Manufacturing Cloud accelerates the end-to-end drug product lifecycle by connecting together distributed teams and sites, helping them execute better on the shop floor, and optimizing their operations through enterprise-wide visibility. From preclinical benchtop to large-scale commercial manufacturing, Tempo keeps your global teams connected, empowered, and in sync. 

With $207M in funding, a 3.4x growth YoY rate, and 218% net customer retention, Apprentice is a trusted partner to modernize your operations and change the way drugs are made in your facility. Learn how leading companies like Synthego and Bristol Myers Squibb are using Tempo to scale from drug discovery to patient delivery faster at www.apprentice.io.

Contact Information:

Marie Forshaw

VP, Marketing

[email protected]

Kristen Kucks

Director of Communications, Marketing

[email protected]

Original Source:

Apprentice Announces Major Tempo Manufacturing Cloud Release Built to Support Commercial Manufacturing of the Future

The post Apprentice Announces Major Tempo Manufacturing Cloud Release Built to Support Commercial Manufacturing of the Future first appeared on Enrose Magazine.

Continue Reading

LevelUp MD Urgent Care Celebrates National Immunization Awareness Month: Promoting a Healthier Future Through Vaccination Advocacy

LevelUp MD Urgent Care Celebrates National Immunization Awareness Month: Promoting a Healthier Future Through Vaccination Advocacy

Elevating Community Health: August Marks National Immunization Month, a Time to Raise Awareness and Promote Lifesaving Vaccinations. LevelUp MD Urgent Care Encourages Keeping Immunization Records Up-to-Date.

The post LevelUp MD Urgent Care Celebrates National Immunization Awareness Month: Promoting a Healthier Future Through Vaccination Advocacy first appeared on Enrose Magazine.

Continue Reading

BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% Accuracy

BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% Accuracy

In a clinical validation study published on Scientific Reports, UNITY RhD NIPT and Fetal antigen NIPT demonstrated 100% sensitivity, 100% specificity, 99.9% precision with 0.1% no-call rate across 3,921 NIPT assays.

The post BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% Accuracy first appeared on Enrose Magazine.

Continue Reading

Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology

Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology

The ImageneOI rapid AI-based biomarker profiling platform significantly improves lung cancer patient outcomes, as demonstrated by a recently published case report.

Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology
ImageneOI Platform and Case Report

ImageneOI AI-based Molecular Profiling Platform on OCI, and the published case report of impacting patients’ lives.

Imagene, an emerging leader in AI-based precision oncology, is proud to announce the launch of the ImageneOI platform on Oracle Cloud Infrastructure (OCI). The innovative platform, supported by proven clinical benefits, sets a new paradigm in cancer diagnostics by enabling rapid AI-based molecular profiling from biopsy images alone, overcoming key barriers and limitations in current diagnostic processes. ImageneOI already proved its significant impact under research on treatment initiation and averting radiation for two cancer patients, as published in a recent case report in the Journal of Clinical Pathology.

“We’re confident in selecting Oracle as our cloud provider and are pleased to join forces with Oracle in our mission to make advanced technologies drive better patient care,” said Dean Bitan, co-founder and CEO of Imagene. “Oracle is not only delivering consistent, high-performance computing with widespread global reach, but its focus on the healthcare sector has played a crucial role in enabling us to bring this transformative service to the forefront of cancer diagnostics.”

For AI inference computation and to process data at scale, Imagene partnered with Oracle to run its ImageneOI platform on OCI and will take advantage of OCI Supercluster and OCI AI infrastructure technology. OCI’s cost-effective, high-performance computing enables the ImageneOI platform to offer rapid biomarker profiling and to deliver impressive performance of approximately two minutes from uploading a digitized biopsy image to receiving a biomarkers status report. 

“Saving lives is technology’s single most important use,” said Safra Catz, CEO of Oracle. “We are proud that Oracle’s highly performant and secure cloud infrastructure will help Imagene improve access to care, drive informed decisions, lower costs, and ultimately save lives.”

ImageneOI aligns with oncology clinical guidelines that emphasize the importance of obtaining molecular testing for actionable cancer biomarkers before initiating treatment. This breakthrough technology paves the way for improved and personalized cancer care. It facilitates informed decision-making for optimal treatment strategies by reducing turnaround times from weeks to minutes.

The platform transforms cancer diagnosis by addressing a significant gap in the current healthcare landscape. In the United States, approximately 80 percent of cancer patients choose to receive treatment in community settings. In addition, 64 percent of lung cancer patients, which is the deadliest cancer, do not receive the optimal treatment mostly due to biomarker testing-related challenges and limited access to comprehensive Next-Generation Sequencing (NGS). Up to 30 percent of tested patients do not receive guidelines-recommended biomarkers testing results prior to first-line therapy initiation. This accessibility issue and under-tested populations presents a major obstacle to effective cancer treatment.

The pressing need and demand for rapid and accurate cancer diagnosis pose a significant challenge in advancing precision oncology. This challenge is highlighted by the projected rise in cancer incidence, lengthy turnaround times, and issues with tissue inadequacy. The accessibility of the ImageneOI platform on OCI makes it an invaluable rapid molecular profiling resource for research institutions and medical centers globally.

In conjunction with the launch, Imagene is initiating an Early Access Research Program. Interested parties are encouraged to get in touch for more information at [email protected].

About Oracle:

Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.

About Imagene:

Imagene is an emerging leader in AI-based precision oncology. The company leverages AI to profile, within minutes, a broad range of cancer biomarkers from a digitized biopsy image alone, providing physicians with immediate oncology intelligence to ensure optimal treatment for all cancer patients. Visit imagene-ai.com 

Trademarks

Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company–ushering in the new era of cloud computing.

Contact Information:

Avital Rabani

Head of Marketing

[email protected]

Original Source:

Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology

The post Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology first appeared on Enrose Magazine.

Continue Reading